Study of Abituzumab in Combination With Cetuximab and FOLFIRI in Patients With Metastatic Colorectal Cancer.
Clinical trial NCT03688230 · WITHDRAWN
Trial details
- NCT number
- NCT03688230
- Sponsor
- SFJ Pharmaceuticals X, LTD.
- Status
- WITHDRAWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-01
- Primary completion
- 2020-12-01
- Enrollment
- 0
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.